Live News EQUITY FLASH L impact Nov 16, 2026, 09:06 PM UTC Gilead Expands Remdesivir Licensing to Filovirus Disease Gilead expanded its voluntary remdesivir licensing agreements to include filovirus disease. GILD SquawkNews Desk